Cite

HARVARD Citation

    Tai, C. et al. (2016). Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. Medicine. 95 (15), p. . [Online]. 
  
Back to record